Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial).
Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial).
复制标题
DOI:
10.1007/s00520-018-4263-5
复制
发表时间:
2018-11
期刊:
影响因子:
--
通讯作者:
Walenkamp AME
中科院分区:
文献类型:
--
作者:
Ormel HL;van der Schoot GGF;Westerink NL;Sluiter WJ;Gietema JA;Walenkamp AME
Evidence accumulates that an active lifestyle positively influences cancer treatment outcome. A “smartphone application” (app) such as “RunKeeper,” to self-monitor physical activity (PA) might be helpful. This study aimed to examine whether using RunKeeper to increase self-reported PA is feasible in cancer patients and to evaluate patients’ opinion about using RunKeeper in a 12-week program. Adult patients (n = 32), diagnosed with cancer, were randomized between usual care (n = 16) or a 12-week intervention with instructions to self-monitor PA with RunKeeper (n = 16). Changes in PA were determined with the Physical Activity Scale for the Elderly (PASE) at baseline (T0), 6 weeks (T1), and 12 weeks (T2). Usability and patients’ experiences were tested at T2 with the System Usability Scale (SUS) and a semi-structured interview. Patient mean age was 33.6 years. Between T0 and T1, an increase in PA of 51% (medium estimated effect size r = 0.40) was found in PASE sum score in the intervention group compared with usual care. In addition, total minutes of PA increased with 46% (r = 0.37). These effects decreased over time (T2). Sedentary time decreased with 19% between T0 and T1 and 27% between T0 and T2. Usability was rated “good” and most patients found RunKeeper use helpful to improve PA. Self-monitoring PA with RunKeeper was safe and feasible in cancer patients. The RunKeeper use resulted in an increase in PA after 6 weeks. RunKeeper usability was rated good and can be used to study PA in cancer patients. NCT02391454 The online version of this article (10.1007/s00520-018-4263-5) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1093/annonc/mdu042
发表时间:
2014-10
期刊:
Annals of oncology : official journal of the European Society for Medical Oncology
影响因子:
--
作者:
Chan DSM;Vieira AR;Aune D;Bandera EV;Greenwood DC;McTiernan A;Navarro Rosenblatt D;Thune I;Vieira R;Norat T
通讯作者:
Norat T
影响因子:
5
作者:
Robertson MC;Tsai E;Lyons EJ;Srinivasan S;Swartz MC;Baum ML;Basen-Engquist KM
通讯作者:
Basen-Engquist KM
影响因子:
3.7
作者:
King AC;Hekler EB;Grieco LA;Winter SJ;Sheats JL;Buman MP;Banerjee B;Robinson TN;Cirimele J
通讯作者:
Cirimele J
影响因子:
45.3
作者:
Harrigan, Maura;Cartmel, Brenda;Irwin, Melinda L.
通讯作者:
Irwin, Melinda L.
影响因子:
3.1
作者:
Ottenbacher, Allison J.;Day, R. Sue;Demark-Wahnefried, Wendy
通讯作者:
Demark-Wahnefried, Wendy